Details for New Drug Application (NDA): 019548
✉ Email this page to a colleague
The generic ingredient in TORNALATE is bitolterol mesylate. Additional details are available on the bitolterol mesylate profile page.
Summary for 019548
Tradename: | TORNALATE |
Applicant: | Sanofi Aventis Us |
Ingredient: | bitolterol mesylate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION | Strength | 0.2% | ||||
Approval Date: | Feb 19, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 019548
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription